Masimo Corp is a technology company... Show more
The Moving Average Convergence Divergence (MACD) for MASI turned positive on April 22, 2025. Looking at past instances where MASI's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MASI's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where MASI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on MASI as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MASI advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .
MASI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MASI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MASI entered a downward trend on April 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MASI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.615) is normal, around the industry mean (23.728). P/E Ratio (95.927) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (4.833) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.826) is also within normal values, averaging (41.794).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MASI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
a developer of medical signal processing technologies
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KOCT | 28.52 | 0.22 | +0.76% |
Innovator US Small Cap Pwr Buff ETF™ Oct | |||
IQDG | 35.93 | 0.22 | +0.62% |
WisdomTree International Qual Div Gr ETF | |||
BHV | 10.26 | 0.05 | +0.49% |
BlackRock Virginia Muni | |||
BSMP | 24.39 | 0.01 | +0.02% |
Invesco BulletShares 2025 Muncpl Bd ETF | |||
SCHH | 20.62 | -0.01 | -0.05% |
Schwab US REIT ETF™ |
A.I.dvisor indicates that over the last year, MASI has been loosely correlated with INSP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then INSP could also see price increases.
Ticker / NAME | Correlation To MASI | 1D Price Change % | ||
---|---|---|---|---|
MASI | 100% | +5.71% | ||
INSP - MASI | 50% Loosely correlated | -0.23% | ||
HBIO - MASI | 45% Loosely correlated | +0.97% | ||
VCYT - MASI | 41% Loosely correlated | +1.08% | ||
PODD - MASI | 40% Loosely correlated | +0.95% | ||
MMSI - MASI | 39% Loosely correlated | +2.47% | ||
More |